Login
$VIVC
$0.01 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In USD, except per-share amounts
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Q4 FY2025
As of Jun 30, 2025
Q3 FY2025
As of Mar 31, 2025
Q2 FY2025
As of Dec 31, 2024
Q1 FY2025
As of Sep 30, 2024
Q4 FY2024
As of Jun 30, 2024
Q3 FY2024
As of Mar 31, 2024
Q2 FY2024
As of Dec 31, 2023
Q1 FY2024
As of Sep 30, 2023
Q4 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Mar 31, 2023
Q2 FY2023
As of Dec 31, 2022
Q1 FY2023
As of Sep 30, 2022
Q4 FY2022
As of Jun 30, 2022
Q3 FY2022
As of Mar 31, 2022
Q1 FY2022
As of Sep 30, 2021
Q4 FY2021
As of Jun 30, 2021
ASSETS
Current assets
Cash and cash equivalents
Accounts receivable - related party
Related Party
Total accounts receivable - related party
Note receivable
Prepayments
Nonrelated Party
Related Party
Total prepayments
Other receivables
Nonrelated Party
Related Party
Total other receivables
Inventory
Nonrelated Party
Total inventory
Total current assets
Non-current assets
Due from related parties
Property and equipment, net
Nonrelated Party
Total property and equipment, net
Intangible assets, net
Assets from discontinued operations
Total non-current assets
Assets classified as held for sale
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable
Nonrelated Party
Related Party
Total accounts payable
Accrued liabilities and other payables
Nonrelated Party
Total accrued liabilities and other payables
Deferred revenue
Tax payable
Due to related parties
Related Party
Total due to related parties
Income tax payable
Short-term loan
Total current liabilities
Non-Current liabilities
SBA loan payable
Liabilities from discontinued operations
Long-term loan
Total non-current liabilities
TOTAL LIABILITIES
STOCKHOLDERS’ EQUITY
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 832,000 shares issued and outstanding as of March 31, 2026 and June 30, 2025
Common stock, $0.001 par value; 70,000,000 shares authorized; 27,678,419 shares issued and outstanding as of March 31, 2026, and 27,410,921 shares issued and outstanding as of June 30, 2025
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity (deficit)
Total stockholders’ equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support